Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Capsule, Extended Release
Product Images NDC 63629-1978

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate (NDC 63629-1978). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Image 01)

A pharmacokinetic line graph showing mean plasma concentrations (ng/mL) of dextroamphetamine and levoamphetamine over 24 hours. It compares extended-release capsules and tablet formulations of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate at different dosages and dosing schedules, with time on the x-axis and plasma concentration on the y-axis.*

FDA Label Image

Label (Lbl636291978)

Label for Dextroamphetamine Sulf-Saccharate/Amphetamine Sulf-Aspartate ER, USP extended-release capsules, strength 5 mg, manufactured by UPM Pharmaceuticals Inc. and relabeled by Bryant Ranch Prepack. The package contains 100 capsules and is labeled Rx only. The NDC is 63629-1978-1. Storage and safety instructions are included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.